Concepedia

Author

C. Rosak

Krankenhaus Sachsenhausen

Also Known As

A. Monroy-Mayorga, C Rosak, C. ROSAK, C. Rosak, Ch. Rosak

94

Publications

580

Citations

12

H-Index

36

Concepts

All Affiliations

Krankenhaus SachsenhausenGlaxoSmithKline (Germany)
CR

About

C. Rosak is an author at Krankenhaus Sachsenhausen specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

234

2

Diabetes

3

3

80

3

Health Sciences

1

1

27

4

Public Health

1

1

30

5

Biochemistry

1

1

27

C. Rosak

×

8

Publications

320

Citations

8

H-Index

YearCitations

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz,

Queensland's institutional digital repository (The University of Queensland)

1996

154

The Effect of the Timing and the Administration of Acarbose on Postprandial Hyperglycaemia

C. Rosak, G. Nitzsche, P König,

Diabetic Medicine

1995

31

Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.

Breddin Hk, Krzywanek Hj, P.-H. Althoff,

PubMed

1987

30

Comparative Studies on Intermediary Metabolism and Hormonal Counterregulation Following Human Insulin (recombinant DNA) and Purified Pork Insulin in Man

C. Rosak, P.-H. Althoff, F. Enzmann

Diabetes Care

1982

27

Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes

C. Rosak, R. Petzoldt, Robert Wolf,

International Journal of Clinical Practice

2005

23

The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.

C. Rosak, E Haupt, T.A. Walter,

PubMed

2002

23

Treatment with Human Insulin (recombinant DNA) in Diabetic Subjects Pretreated with Pork or Beef Insulin: First Results of a Multicenter Study

J. Beyer, F. Enzmann, M Lauerbach,

Diabetes Care

1982

20

Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes

C. Rosak, Eberhard Standl, Tjark Reblin,

International Journal of Clinical Practice

2006

12

Page 1